...applicant's actions during the regulatory review period to determine whether the applicant exhibited that degree of attention, continuous directed effort,...exercised by, a person during a regulatory review period. FDA will take into consideration all relevant factors, such as the amount of time between the approval...

...applicant's actions during the regulatory review period to determine whether the applicant exhibited that degree of attention, continuous directed effort,...exercised by, a person during a regulatory review period. FDA will take into consideration all relevant factors, such as the amount of time between the approval...

...that degree of attention, continuous directed effort, and §60.30 Food and Drug Administration, HHS timeliness as may reasonably be expected from, and...exercised by, a person during a regulatory review period. FDA will take into consideration all relevant factors, such as the amount of time between the approval...

...Commissioner of Fooo and Drugs. "(3) For the purposes of paragraph (2KB), the term 'due diligence' means that degree of attention, continuous directed effort,...exercised by, a person during a regulatory review period. "(4) An application for the extension of the term of a patent is subject to the disclosure requirements...

...in the Federal Register. "'3) For the purposes of paragraph < 2xB). the term 'due diligence' means that degree of attention, continuous directed effort,...ordinarily exercised by, a person during a regulatory ieview period. "'4) An application for the extension of the term of a patent is subject to the disclosure...

...involving the infringement of a patent. (E) For purposes of this paragraph, the term "due diligence" means that degree of attention, continuous directed effort,...exercised by, a person during a regulatory review period. (F) In a proceeding under this paragraph, the Administrator may take into consideratioin the failure...

...of a drug if the applicant has demonstrated that degree of attention and continuous directed effort as may reasonably be expected from, and are ordinarily exercised by, a person before approval or licensing of a drug, such as the preparation for and the conduct of preclinical...

...applicant's actions during the regulatory review period to determine whether the applicant exhibited the degree of attention, continuous directed effort, and...exercised by, a person during a regulatory review period. APHIS will take into consideration all relevant factors, such as the amount of time between the approval...

...applicant's actions during the regulatory review period to determine whether the applicant exhibited that degree of attention, continuous directed effort,...exercised by, a person during a regulatory review period. FDA will take into consideration all relevant factors, such as the amount of time between the approval...

...defines "due diligence" a* "that degree of attention, continuous directed effort, and timeliness as say reasonably be expected from, and are ordinarily exercised by, a person during a regulatory review period." The purpose of the due diligence provision is to ensure that patent holders are not compensated for...